Structural basis for botulinum neurotoxin E recognition of synaptic vesicle protein 2

[1]  G. Masuyer,et al.  Mechanism of Ganglioside Receptor Recognition by Botulinum Neurotoxin Serotype E , 2021, International journal of molecular sciences.

[2]  Yoshiki Narimatsu,et al.  Global view of human protein glycosylation pathways and functions , 2020, Nature Reviews Molecular Cell Biology.

[3]  K. Lam,et al.  Two VHH Antibodies Neutralize Botulinum Neurotoxin E1 by Blocking Its Membrane Translocation in Host Cells , 2020, Toxins.

[4]  K. Lam,et al.  Camelid VHH Antibodies that Neutralize Botulinum Neurotoxin Serotype E Intoxication or Protease Function , 2020, Toxins.

[5]  K. Lam,et al.  Structural Insights into Rational Design of Single-Domain Antibody-Based Antitoxins against Botulinum Neurotoxins , 2020, Cell reports.

[6]  M. Volteau,et al.  Safety and pharmacodynamics of a novel recombinant botulinum toxin E (rBoNT-E): Results of a phase 1 study in healthy male subjects compared with abobotulinumtoxinA (Dysport®) , 2019, Journal of the Neurological Sciences.

[7]  G. Schneider,et al.  Structural Insights Into The Interaction Of Botulinum Neurotoxin A With Its Neuronal Receptor SV2C. , 2019, Toxicon : official journal of the International Society on Toxinology.

[8]  Eric A. Johnson,et al.  Botulinum neurotoxins A, B, C, E, and F preferentially enter cultured human motor neurons compared to other cultured human neuronal populations , 2019, FEBS letters.

[9]  G. Masuyer,et al.  Botulinum and Tetanus Neurotoxins. , 2019, Annual review of biochemistry.

[10]  H. Hammad,et al.  Protein crystallization promotes type 2 immunity and is reversible by antibody treatment , 2019, Science.

[11]  J. Novak,et al.  Glycosylation in health and disease , 2019, Nature Reviews Nephrology.

[12]  Mark Elliott,et al.  Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models , 2019, Science Advances.

[13]  J. Krupp,et al.  The Expanding Therapeutic Utility of Botulinum Neurotoxins , 2018, Toxins.

[14]  G. Masuyer,et al.  Crystal Structure of Botulinum Neurotoxin A2 in Complex with the Human Protein Receptor SV2C Reveals Plasticity in Receptor Binding , 2018, Toxins.

[15]  K. Lam,et al.  A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding , 2017, Scientific Reports.

[16]  J. Krupp,et al.  Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors , 2017, Nature Communications.

[17]  R. Franzen,et al.  Puzzling Out Synaptic Vesicle 2 Family Members Functions , 2017, Front. Mol. Neurosci..

[18]  C. Montecucco,et al.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology , 2017, Pharmacological Reviews.

[19]  Martin A. Schärer,et al.  Crystal structure of the BoNT/A2 receptor-binding domain in complex with the luminal domain of its neuronal receptor SV2C , 2017, Scientific Reports.

[20]  K. Lam,et al.  N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A , 2016, Nature Structural &Molecular Biology.

[21]  D. Stern,et al.  Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin , 2016, Toxins.

[22]  R. Zeleny,et al.  Generation and Characterization of Six Recombinant Botulinum Neurotoxins as Reference Material to Serve in an International Proficiency Test , 2015, Toxins.

[23]  H. Bigalke,et al.  Botulinum Neurotoxins: Qualitative and Quantitative Analysis Using the Mouse Phrenic Nerve Hemidiaphragm Assay (MPN) , 2015, Toxins.

[24]  K. Lam,et al.  Architecture of the botulinum neurotoxin complex: a molecular machine for protection and delivery. , 2015, Current opinion in structural biology.

[25]  K. Lam,et al.  Diverse binding modes, same goal: The receptor recognition mechanism of botulinum neurotoxin. , 2015, Progress in biophysics and molecular biology.

[26]  C. Montecucco,et al.  Botulinum neurotoxins: genetic, structural and mechanistic insights , 2014, Nature Reviews Microbiology.

[27]  Xavier Robert,et al.  Deciphering key features in protein structures with the new ENDscript server , 2014, Nucleic Acids Res..

[28]  J. Marks,et al.  Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin A , 2014, FEBS letters.

[29]  K. Acharya,et al.  Engineered botulinum neurotoxins as new therapeutics. , 2014, Annual review of pharmacology and toxicology.

[30]  T. Ceska,et al.  Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A , 2013, Nature.

[31]  Lei Jin,et al.  Structure of a Bimodular Botulinum Neurotoxin Complex Provides Insights into Its Oral Toxicity , 2013, PLoS pathogens.

[32]  R. Berntsson,et al.  Structure of dual receptor binding to botulinum neurotoxin B , 2013, Nature Communications.

[33]  M. Caleo,et al.  Botulinum Neurotoxins A and E Undergo Retrograde Axonal Transport in Primary Motor Neurons , 2012, PLoS pathogens.

[34]  B. Antonsson,et al.  Differences in the glycosylation of recombinant proteins expressed in HEK and CHO cells. , 2012, Journal of biotechnology.

[35]  D. Covas,et al.  Human cells: new platform for recombinant therapeutic protein production. , 2012, Protein expression and purification.

[36]  C. Shoemaker,et al.  Botulinum Neurotoxin Is Shielded by NTNHA in an Interlocked Complex , 2012, Science.

[37]  Eric A. Johnson,et al.  Botulinum Neurotoxin D Uses Synaptic Vesicle Protein SV2 and Gangliosides as Receptors , 2011, PLoS pathogens.

[38]  Eric A. Johnson,et al.  SV2 Mediates Entry of Tetanus Neurotoxin into Central Neurons , 2010, PLoS pathogens.

[39]  B. Spiegelman,et al.  Retrograde influence of muscle fibers on their innervation revealed by a novel marker for slow motoneurons , 2010, Development.

[40]  Mauricio Montal,et al.  Botulinum neurotoxin: a marvel of protein design. , 2010, Annual review of biochemistry.

[41]  R. Jahn,et al.  Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation‐dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor , 2009, Journal of neurochemistry.

[42]  J. Barbieri,et al.  Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F. , 2009, Biochemistry.

[43]  J. Navaza,et al.  Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation. , 2008, Journal of molecular biology.

[44]  Edwin R Chapman,et al.  Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. , 2008, Molecular biology of the cell.

[45]  J. Marth,et al.  Mammalian glycosylation in immunity , 2008, Nature Reviews Immunology.

[46]  R. Stevens,et al.  Crystal Structure of Botulinum Neurotoxin Type A in Complex with the Cell Surface Co-Receptor GT1b—Insight into the Toxin–Neuron Interaction , 2008, PLoS pathogens.

[47]  R. Stevens,et al.  Structural basis of cell surface receptor recognition by botulinum neurotoxin B , 2006, Nature.

[48]  Axel T. Brunger,et al.  Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity , 2006, Nature.

[49]  W. Jost,et al.  Botulinum toxin: clinical use. , 2006, Parkinsonism & related disorders.

[50]  Eric A. Johnson,et al.  SV2 Is the Protein Receptor for Botulinum Neurotoxin A , 2006, Science.

[51]  B. Davletov,et al.  The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves , 2006, FEBS letters.

[52]  G. Schiavo,et al.  Presynaptic receptor arrays for clostridial neurotoxins. , 2004, Trends in microbiology.

[53]  J. Jankovic,et al.  Botulinum toxin in clinical practice , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[54]  J. Keller,et al.  Uptake of botulinum neurotoxin into cultured neurons. , 2004, Biochemistry.

[55]  R. Stevens,et al.  Crystal structure of botulinum neurotoxin type A and implications for toxicity , 1998, Nature Structural Biology.

[56]  F. Corpet.  Multiple sequence alignment with hierarchical clustering. , 1988, Nucleic acids research.

[57]  C. Montecucco.  How do tetanus and botulinum toxins bind to neuronal membranes , 1986 .

[58]  J. Skehel,et al.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. , 2000, Annual review of biochemistry.

[59]  A. Brünger.  Free R value: a novel statistical quantity for assessing the accuracy of crystal structures , 1992, Nature.